Tsai and colleagues note that even though meds like Wegovy and Zepbound are effective in helping people shed pounds, the drugs' "high cost and high rates of gastrointestinal adverse effects can lead to treatment cessation and subsequent weight regain." Demand for weight-loss meds has also outstripped supply, so it's possible that the number of weight-loss surgery patients may rise again if "ongoing national shortages" of GLP-1s continue, the research team added
Philippe K, Teo S, Perrotta C, McAuliffe FM, Phillips CM
This study is very new and the findings have not yet been explored or duplicated by any other research team
Always consult your physician if you have health concerns, take other medications, or have any questions before starting any new prescription treatment
As with all insulins, the glucose lowering effect time course of insulin glargine products may vary in different patients or at different times in the same patient and depends on many conditions, including the area of injection as well as the injection site blood supply and temperature [see CLINICAL PHARMACOLOGY ]
A: Indirectly yes